Cargando…
Genomic aberrations associated with outcome in anaplastic oligodendroglial tumors treated within the EORTC phase III trial 26951
Despite similar morphological aspects, anaplastic oligodendroglial tumors (AOTs) form a heterogeneous clinical subgroup of gliomas. The chromosome arms 1p/19q codeletion has been shown to be a relevant biomarker in AOTs and to be perfectly exclusive from EGFR amplification in gliomas. To identify ne...
Autores principales: | Idbaih, Ahmed, Dalmasso, Cyril, Kouwenhoven, Mathilde, Jeuken, Judith, Carpentier, Catherine, Gorlia, Thierry, Kros, Johan M., French, Pim, Teepen, Johannes, Broët, Philippe, Delattre, Olivier, Mokhtari, Karima, Sanson, Marc, Delattre, Jean-Yves, van den Bent, Martin, Hoang-Xuan, Khê |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Springer US
2010
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3097344/ https://www.ncbi.nlm.nih.gov/pubmed/20820870 http://dx.doi.org/10.1007/s11060-010-0380-9 |
Ejemplares similares
-
Joint Final Report of EORTC 26951 and RTOG 9402: Phase III Trials With Procarbazine, Lomustine, and Vincristine Chemotherapy for Anaplastic Oligodendroglial Tumors
por: Lassman, Andrew B., et al.
Publicado: (2022) -
Anaplastic oligodendrogliomas with 1p19q codeletion have a proneural gene expression profile
por: Ducray, François, et al.
Publicado: (2008) -
Integrated multi-omics analysis of oligodendroglial tumours identifies three subgroups of 1p/19q co-deleted gliomas
por: Kamoun, Aurélie, et al.
Publicado: (2016) -
MGMT promoter hypermethylation is a frequent, early, and consistent event in astrocytoma progression, and not correlated with TP53 mutation
por: Groenendijk, Floris H., et al.
Publicado: (2010) -
NOTCH2 Is Neither Rearranged nor Mutated in t(1;19) Positive Oligodendrogliomas
por: Benetkiewicz, Magdalena, et al.
Publicado: (2009)